Kappa Bioscience AS Revenue and Competitors

Kappa Bioscience is the pioneer in development and production of the only synthetic and biologically active all-trans menaquinone-7 (vitamin K2 MK-7), marketed under the K2VITAL® brand name. Kappa's innovation of MK-7 synthesis marks the commercial milestone where this fat-soluble vitamin can begin to attain widespread consumer adoption. Effective synthesis production drives scalability, price reduction and a secure supply chain - with unmatched ingredient purity and documentation. Combined with other Kappa innovations such as the patented DELTA® microencapsulation process, which provides K2 stability in mineral formulations, K2VITAL® offers brands and manufacturers a path to broader market segments. Kappa Ingredients GmbH, a wholly owned division of Kappa Bioscience, manages global sales of the K2VITAL® and other product lines directly and through a network of global distributors. Kappa Ingredients GmbH, a wholly owned division of Kappa Bioscience, manages global sales of the K2VITAL® and other product lines - Ingredients and services related to Bones, Joints and Cardiovascular Health - directly and through a network of global distributors. Main products are Vitamin K2 - K2VITAL®, Calcified Atlantic Seaweed®, The Bone Health Triangle®.